Recommendations from a national conference on universal vaccination against hepatitis B and hepatitis A in adults

Eugene R. Schiff, Bradley A. Connor, Jody H. Hershey, Martin C. Mahoney, William Schaffner

Research output: Contribution to journalArticle


The Centers for Disease Control and Prevention (CDC) estimate that, in the United States, 78,000 people became infected with hepatitis B in 2001 and that 93,000 cases of hepatitis A occurred in 2002. Current recommendations of the CDC's Advisory Committee on Immunization Practices (ACIP) for hepatitis B and hepatitis A vaccination in adults are based on a daunting list of risk groups, many of which overlap. Simplifying vaccination recommendations and using the term "vaccine-preventable hepatitis" (VPH) may encourage practitioners to administer hepatitis B and hepatitis A vaccines to adults. A group of experts in the fields of primary care, gastroenterology, hepatology, infectious and sexually transmitted diseases, human immunodeficiency virus, travel medicine, and public health convened to discuss prevention of hepatitis B and hepatitis A and to develop recommendations for VPH based on available evidence. They concluded that a universal, age-based vaccination strategy would help to increase vaccination rates among adults, thereby decreasing the incidence of hepatitis B and hepatitis A, and that government funding of hepatitis B and hepatitis A vaccination in adults is needed.

Original languageEnglish (US)
Pages (from-to)3-16
Number of pages14
JournalJournal of Applied Research
Issue number1
StatePublished - Apr 26 2007



  • Hepatitis A
  • Hepatitis B
  • Prevention
  • Recommendations
  • Vaccine

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology

Cite this